Journey Medical Corp financial data

Symbol
DERM on Nasdaq
Location
Scottsdale, AZ
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 135 % +1.97%
Quick Ratio 33.2 % +16.4%
Debt-to-equity 282 % -27.8%
Return On Equity -39.9 % +69.8%
Return On Assets -10.5 % +61.2%
Operating Margin -24.4 % -831%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 50.1M USD +309%
Weighted Average Number of Shares Outstanding, Basic 25M shares +21.5%
Weighted Average Number of Shares Outstanding, Diluted 25M shares +21.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 17.6M USD +20.5%
Revenue from Contract with Customer, Excluding Assessed Tax 57.8M USD +0.04%
Cost of Revenue 20.9M USD -8.8%
Research and Development Expense 287K USD -65.9%
Costs and Expenses 64.9M USD -14.4%
Operating Income (Loss) -5.5M USD +69.5%
Nonoperating Income (Expense) -3.05M USD -1463%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -8.54M USD +53.1%
Income Tax Expense (Benefit) 60K USD
Net Income (Loss) Attributable to Parent -8.66M USD +52.8%
Earnings Per Share, Basic 0 USD/shares +63.7%
Earnings Per Share, Diluted 0 USD/shares +58.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 24.9M USD +11.1%
Accounts Receivable, after Allowance for Credit Loss, Current 18M USD +68.5%
Inventory, Net 11.8M USD +0.25%
Assets, Current 56.4M USD +22.2%
Operating Lease, Right-of-Use Asset 134K USD +319%
Intangible Assets, Net (Excluding Goodwill) 28.7M USD +60.7%
Other Assets, Noncurrent 6K USD 0%
Assets 85.2M USD +33%
Accounts Payable, Current 11.6M USD -24.7%
Accrued Liabilities, Current 21.2M USD +32.4%
Liabilities, Current 39.7M USD +19.1%
Operating Lease, Liability, Noncurrent 44K USD
Liabilities 59.3M USD +11.6%
Retained Earnings (Accumulated Deficit) -97.2M USD -9.78%
Stockholders' Equity Attributable to Parent 25.9M USD +137%
Liabilities and Equity 85.2M USD +33%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.83M USD +43.6%
Net Cash Provided by (Used in) Financing Activities 3.6M USD +120%
Net Cash Provided by (Used in) Investing Activities -5M USD +75%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 765K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 24.9M USD +11.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 813K USD +204%
Deferred Tax Assets, Valuation Allowance 24M USD +19.3%
Deferred Tax Assets, Gross 24.1M USD +19.4%
Operating Lease, Liability 142K USD +318%
Lessee, Operating Lease, Liability, to be Paid 149K USD +338%
Operating Lease, Liability, Current 98K USD +188%
Lessee, Operating Lease, Liability, to be Paid, Year Two 18K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 105K USD +1067%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure +16%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 18K USD
Deferred Tax Assets, Operating Loss Carryforwards 6.81M USD +55.7%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 123M USD +23.8%
Amortization of Intangible Assets 4.18M USD +30.7%
Deferred Tax Assets, Net of Valuation Allowance 50K USD +100%
Share-based Payment Arrangement, Expense 5.89M USD +12.2%
Interest Expense 1.6M USD -30%